Jubilant Ingrevia Q1FY27 Results: Consolidated Revenue ₹13,003 Crore, Profit ₹105.82 Crore
Jubilant Ingrevia reported Q1FY27 results with consolidated revenue at ₹13,003 crore and profit after tax of ₹10,582 crore. Standalone profit after tax was ₹12,622 crore. The company maintained strong debt service coverage ratios and operating margins.
The results are in line with expectations for a company of this size and sector, showing steady performance.
The company reported positive financial results with growth in revenue and profit compared to the previous year.
Jubilant Ingrevia Limited announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The Board of Directors approved these results in a meeting held on July 22, 2026.
On a consolidated basis, the company reported a total income of ₹13,104.9 crore for the quarter. Expenses amounted to ₹11,696.0 crore, leading to a profit before tax of ₹14,086 crore. After accounting for tax expenses of ₹4,296 crore, the net profit for the quarter stood at ₹10,582 crore. Other comprehensive income was ₹274 crore, resulting in a total comprehensive income of ₹11,088 crore. The diluted Earnings Per Share (EPS) for the quarter was ₹6.68.
Key financial metrics for the consolidated results include a Debt service coverage ratio of 4.81, Interest service coverage ratio of 12.01, Operating margin of 11.39%, and Net profit margin of 8.07%. The Net worth was ₹3,24,145 lakh, and the Debt equity ratio was 0.22.
For the standalone results, the total income for the quarter was ₹12,632.2 crore, with expenses at ₹10,936.1 crore, resulting in a profit before tax of ₹16,961 crore. The net profit after tax of ₹3,959 crore was ₹12,622 crore. The diluted EPS was ₹7.92.
Standalone financial metrics show a Debt service coverage ratio of 5.83, Interest service coverage ratio of 15.69, Operating margin of 13.84%, and Net profit margin of 9.99%. The Net worth was ₹2,77,067 lakh, and the Debt equity ratio was 0.23.
The company also provided segment-wise revenue and results. For consolidated operations, Speciality Chemicals contributed ₹83,70.0 crore in revenue and ₹10,91.4 crore in profit before tax. Nutrition & Health Solutions reported ₹24,38.2 crore in revenue and ₹2,82.6 crore in profit before tax. Chemical Intermediates generated ₹52,51.7 crore in revenue and ₹4,39.7 crore in profit before tax.
The company's website www.jubilantngrevia.com will host the financial results.
What to do with a filing like this
Jubilant Ingrevia Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Jubilant Ingrevia Limited. Read the original for the full detail.